These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 1378811)
1. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811 [TBL] [Abstract][Full Text] [Related]
2. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members]. Miyasaka M Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830 [TBL] [Abstract][Full Text] [Related]
3. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff. Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Oguchi H; Miyasaka M; Tokunaga S; Hora K; Ichikawa S; Ochi T; Yamada K; Nagasawa M; Kanno Y; Aizawa T Clin Nephrol; 1992 Jul; 38(1):36-43. PubMed ID: 1499167 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434 [TBL] [Abstract][Full Text] [Related]
7. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis. Nakayama E; Liu JH; Akiba T; Marumo F; Sato C J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study. Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431 [TBL] [Abstract][Full Text] [Related]
9. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C infection in a pediatric dialysis population. Jonas MM; Zilleruelo GE; LaRue SI; Abitbol C; Strauss J; Lu Y Pediatrics; 1992 Apr; 89(4 Pt 2):707-9. PubMed ID: 1313556 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis. Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521 [TBL] [Abstract][Full Text] [Related]
14. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis. Batchoun RG; Al-Najdawi MA; Al-Taamary S Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340 [TBL] [Abstract][Full Text] [Related]
17. HCV seroprevalence in dialysis patients, their relatives and medical staff. Capşa D; Cernescu S; Constantinescu SN; Cernescu C Rev Roum Virol; 1991; 42(3-4):171-5. PubMed ID: 1667584 [TBL] [Abstract][Full Text] [Related]
19. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection. Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]